Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 24, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/23/17 - 5 Top NASDAQ Biotech Stocks: Novavax Leads the Week
Last week saw the potential for a major development in the gene therapy sector take the spotlight when it was announced the US Food and Drug Administration approved Spark Therapeutics gene therapy for a rare genetically caused blindness. Novavax Agenus Sierra Oncology Durect Cogentix Novavax. Agenus is a company focused on their portfolio of...
7/23/17 - Brain Boosters A Gold Mine For Supplements Industry But Benefits Are Hotly Disputed
A few years ago, motivated by a family history of dementia, Bea Pena-Reames began using a dietary supplement that promised improved memory and brain health. "I'm typically a joyful person, but I couldn't shake this depression and intense sense of sadness," said Pena-Reames, 56, a former high school biology teacher who lives in north Texas. Product
7/23/17 - Demand notices of Rs 74.65 crore issued to pharma companies [India Infoline News Service]
Union Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilisers, Mansukh Lal Mandaviya, informed that during the monitoring of compliance of various provisions of Drugs Order, 2013 by drug manufacturers, it is seen that the provisions related to new drugs have not been followed in some cases, wherein pharmaceut
7/23/17 - Findings from University of Missouri Provides New Data about Orthopedics (The Methodology of Clinical Studies Used by the FDA for Approval of...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Investigators publish new report on Orthopedics. According to news reporting originating in Kansas City, Missouri, by NewsRx journalists, research stated, "The purpose of this investigation was to examine the methodology of clinical trials used by the U.S. Food and Drug Admini
7/23/17 - Findings on Clinical Trials and Studies Detailed by Researchers at University of Washington (Efficacy evaluation of an anti-caries varnish: protocol...
Findings on Clinical Trials and Studies Detailed by Researchers at University of Washington. By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Data detailed on Clinical Research- Clinical Trials and Studies have been presented. Our news journalists obtained a quote from the research from the University of Washington, "The obj
7/23/17 - Global Transdermal Skin Patches Market 2017 Economic Impact Analysis and Industry Research Forecast to 2022
The report titled Transdermal Skin Patches is an in-depth and a professional document that provides a comprehensive overview of the global Transdermal Skin Patches market. The report provides an executive-level blueprint of the Transdermal Skin Patch...
7/23/17 - Janssen Receives Positive CHMP Opinion for SYMTUZA? The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV [India Infoline News Service]
Janssen-Cilag International NV today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a Positive Opinion recommending marketing authorisation for SYMTUZA?, a once-daily darunavir-based single tablet regimen. Darunavir is one of the most widely used HIV treatments in the European Unio
7/23/17 - Letter to the editor: One addiction produces another
Opioid addiction is highest in counties with the largest percentage of Medicaid and Social Security Disability recipients. Legally prescribed opioid drugs in these counties is three to five times higher than average- and so are opioid deaths. This result is paid for by federal funds.
7/23/17 - Pharmaceutical giant Teva to lay off employees at Israel branches [Jerusalem Post (Israel)]
Teva Pharmaceutical Industries on Sunday announced intentions to lay off employees at two Israeli production facilities as part of a company-wide reorganization and effort to strengthen the firm s global brand. Israel, and the Negev in particular, are important to Teva, and our activity here will continue to be a significant part of the compa
7/23/17 - Supply Of Veterinary Medicines, Consumables And Fodder-milk Replacer For The Needs Of Livestock Breeding In Dobrudzha Agricultural Institute - General Toshevo, By Lot": - Lot 1 - "delivery Of Veterinary Medicines And Consumables", With A Maximum Fina
Tenders are invited for "Supply of veterinary medicines, consumables and fodder-milk replacer for the needs of livestock breeding in Dobrudzha Agricultural Institute- General Toshevo, by lot":- Lot 1- "Delivery of veterinary medicines and consumables", with a maximum Financial resource: 35 000 BGN without VAT;- Lot No 2- "Supply of full fodder milk
7/23/17 - Taiwan DCB, PITDC, TMU and Insilico Medicine join forces to apply AI for biomedical research
By a News Reporter-Staff News Editor at VerticalNews Health, Taipei, Taiwan: The Development Center for Biotechnology, the Medical and Pharmaceutical Industrial Technology Development Center, and Taipei Medical University, three of Taiwan's premier biomedical institutions, have teamed up with Baltimore- based Insilico Medicine to develop...
7/23/17 - Worldwide health authorities urged to rethink vitamin D guidelines
By a News Reporter-Staff News Editor at VerticalNews Health Worldwide health authorities are being urged to rethink official guidance around vitamin D following the publication of a ground breaking study from the University of Surrey, which dispels the myth that vitamin D2 and D3 have the same nutritional value. In the first ever study of its kin
7/22/17 - "Kinase Inhibitors" in Patent Application Approval Process (USPTO 20170183343)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAPALDI, Carmelida; ARMANI, Elisabetta; JENNINGS, Andrew Steven Robert; HURLEY, Christopher, filed on December 22, 2016, was made available online on July 6, 2017, according to news reporting originating from Washington, D.C., by NewsRx c
7/22/17 - [I-bank focus]UOBKH lifts CSPC Pharma (01093) to HK$15.24 [ET Net News (China)]
UOB Kay Hian lifted its target price for CSPC. Pharmaceutical Group to HK $15.24 from HK $13.66, and maintained its "buy" rating. The research house held a conference call with CSPC's management.
7/22/17 - Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK [Arab Times (Kuwait)]
The pharma giants said Thursday afternoon that the FDA has accepted their application for erenumab, the furthest advanced CGRP therapy which is now navigating toward a May 17 PDUFA date. But payers will also be expected to consider Eli Lillys 2- day advantage, or a Phase III outcome for Amgen and Novartis that was quite similar to Alders for 70 mg
7/22/17 - Anti-Thrombin Activators Market: Upcoming Demands and Growth Analysis 2024
Transparency Market Research Report Added "Anti-thrombin Activators Market" to its database.Albany, NY 07/21/2017 Anti-thrombin activators are widely accepted due to their role in reducing thrombus formation. Anticoagulants, anti-platelet drugs, and thrombolytic drugs are some of the different types of anti-thrombin activators available, whic
7/22/17 - BrainStorm Wins $15.9M CIRM Grant for Phase III Trial of ALS Cell Therapy [Sport360]
BrainStorm Cell Therapeutics has won a $15.9 million grant from Californias regenerative medicine agency toward a Phase III trial of its amyotrophic lateral sclerosis cell therapy candidate NurOwn. NurOwn technology was developed in the laboratories of Dani Offen, Ph.D., and the late Eldad Melamed, M.D., at Tel Aviv University. BrainStorm said it i
7/22/17 - Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT for the Treatment of Pulmonary Arterial Hypertension
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Cardiome Pharma Corp. announced that partner SteadyMed Ltd submitted a New Drug Application to the U.S. Food and Drug Administration for TREVYENT . TREVYENT is a drug-device combination product that utilizes SteadyMed's PatchPump technology to deliver treprostinil, a.
7/22/17 - CHMP Recommends EU Approval for Roche's TECENTRIQ (Atezolizumab) in a Specific Type of Metastatic Lung and Two Types of Metastatic Bladder Cancer
Roche, a biotech company, issued the following news release:. Roche today announced that the EU Committee for Medicinal Products for Human Use has adopted a positive opinion for TECENTRIQ (R) as a monotherapy for the treatment of adults with locally advanced or metastatic non-small cell lung cancer after they have been previously treated with chemo
7/22/17 - Concert Pharmaceuticals, Lexington, Mass., Assigned Patent for Derivatives of Pyrazole-Substituted Amino-Heteroaryl Compounds
Concert Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by four co-inventors for "derivatives of pyrazole-substituted amino-heteroaryl compounds." The co-inventors are Bhaumik A. Pandya, Arlington, Massachusetts, Craig E. Masse, Cambridge, Massachusetts, Ian Robert Silverman, Arlington, Massachusetts, and Roger D. Tu
7/22/17 - Demand notices of Rs 74.65 crore issued to pharma firms: Government [Syrian Arab News Agency]
The government today said demand notices of Rs 74.65 crore have been issued to pharmaceuticals which have launched drugs without prior price approval from the National Pharmaceuticals Pricing Authority. During the monitoring of compliance of DPCO 2013 by drug makers, it was seen that the provisions related to `new drugs` had not been followed in so
7/22/17 - Dietary Supplements Market to Flourish US $252.1 Bn by 2025
North America is estimated to dominate the dietary supplements market through 2025. The market in Asia Pacific excluding Japan is projected to register the highest CAGR of 9.2% in terms of value between 2015 and 2025. Send an Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-263 Leading market playersKey players covered in the report are...
7/22/17 - Drug prices negotiated downward [China Daily: US Edition]
The prices of 36 expensive drugs- half of them for cancer treatment- are now covered by medical insurance, after the authorities negotiated substantial price reductions. The Ministry of Human Resources and Social Security negotiated with pharmaceutical manufacturers on 44 drugs and managed to cut prices of 36 of them to be acceptable for coverage b
7/22/17 - Egalet Announces Pricing of Public Offering of Common Stock and Warrants
By a News Reporter-Staff News Editor at Marketing Weekly News Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, announced the pricing of its underwritten public offering of 16,666,667 shares of its common stock and...
7/22/17 - Ema's Chmp Issues Positive Opinion for Avelumab for Treatment of Metastatic Merkel Cell Carcinoma
Pfizer, a pharmaceutical company, issued the following news release:. Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of avelumab* as
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415